Clinical trials in San Fermo della Battaglia

Advanced clinical trials focusing on hormone receptor-positive breast cancer treatment strategies, specifically targeting patients whose condition has progressed despite previous therapies.

• Treatment Investigation: Combination therapy assessment with palbociclib and fulvestrant
• Patient Focus: Pre- and post-menopausal women with specific breast cancer markers
• Research Goals: Efficacy and safety evaluation in advanced cases

These studies are exploring innovative approaches for patients with locally advanced or metastatic breast cancer who have experienced progression after initial treatment combinations.

Investigation of targeted therapies involving CDK4/6 inhibitors in combination with hormonal treatments, representing an important advancement in precision medicine approaches.

• Treatment Strategy: Sequential therapy optimization
• Clinical Focus: Hormone receptor-positive cases
• Research Direction: Treatment resistance management

This research aims to provide new treatment options for patients who have developed resistance to previous therapeutic combinations.

Specialized research focusing on advanced breast cancer treatments for women, with particular attention to hormone receptor status and targeted therapeutic approaches.

• Patient Care: Personalized treatment strategies
• Research Focus: Hormone-dependent cancers
• Clinical Advancement: Novel combination therapies

These trials represent significant progress in developing more effective treatments for hormone-dependent breast cancers.